Identification of tuberculous and nontuberculous mycobacteria by biochemical methods is a long-term process that takes up to 8 weeks for completion and requires expertise to interpret the results. In order to detect and differentiate the major pathogenic mycobacterial species, we developed genus-specific primers that amplify the dnaJ gene from the broad spectrum of mycobacterial species and determined the nucleotide sequences within the dnaJ genes from 19 mycobacterial species (Mycobacterium tuberculosis, M. bovis, M. bovis BCG, M. africanum, M. microti, M. kansasii, M. marinum, M. gastri, M. simiae, M. scrofulaceum, M. szulgai, M. gordonae, M. avium, M. intracellulare, M. xenopi, M. fortuitum, M. chelonei, M. haemophilum, and M. paratuberculosis). On the basis of the dnaj gene sequences, we developed dot blot hybridization analysis with species-specific oligonucleotide probes for the M. tuberculosis complex, M. avium, M. intracellulare, and M. kansasii, allowing a rapid identification of these species following polymerase chain reaction for the dnaJ gene. We conclude that polymerase chain reaction with the genus-specific primer that amplifies the dnaJ genes and subsequent dot blot analysis with species-specific oligonucleotide probes are most useful for differential diagnosis of tuberculosis and nontuberculous mycobacterial infections.
Tuberculosis remains one of the most important infectious diseases, even within developed countries. Although it no longer ranks as the most common cause of death, many millions of patients in the world are suffering even today. Nontuberculous mycobacteria, which are widely distributed in nature, can also cause clinically serious diseases for immunocompromised patients. Recently, the number of patients with disseminated infections caused by the Mycobacterium avium-intracellulare complex has dramatically increased since AIDS has become pandemic (6) .
Definitive diagnosis of tuberculosis and nontuberculous infections is provided only by demonstration of the presence of mycobacteria in clinical specimens. Microscopic examination, which has been the basic method for the diagnosis of tuberculosis, requires a relatively large number of bacteria to be present in specimens. Culture confirmation is a sensitive method for detecting mycobacteria, but it takes 3 to 8 weeks and another 2 to 4 weeks for final identification by biochemical analyses. The BACTEC system (Johnson Laboratories, BBL Microbiological Systems, Towson, Md.), which has detected radiolabelled carbon dioxide produced by growing organisms, can detect mycobacteria within short-term culturing; however, it is too expensive and requires radioisotope-handling facilities. Serodiagnosis of tuberculosis is also possible and useful in developing countries, because it is technologically simple. However, serodiagnosis by enzymelinked immunosorbent assay has a value similar only to that of the direct sputum smear (3) . Recently, DNA-RNA hybridization assays have been developed with DNA probes specific for rRNAs of the Mycobacterium tuberculosis complex * Corresponding author.
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and M. avium-intracellulare complex (5, 9) . These probes have greatly reduced the time required for identification, but direct detection and identification of mycobacterial species within clinical specimens are not possible. Currently, polymerase chain reaction (PCR) has been introduced as a sensitive method for detecting mycobacterial DNAs or RNAs (1, 2, 4, 10-14, 16, 17, 19) directly in clinical specimens such as sputum samples or bronchoalveolar lavages.
We demonstrated in the present report that PCR for the dnaJ gene recognizes the broad spectrum of mycobacterial species. We determined the nucleotide sequences of the amplified dnaJ genes of 19 mycobacterial species and developed four species-specific oligonucleotide probes for identifying clinically important mycobacteria such as M. tuberculosis, M. avium, M. intracellulare, and M. kansasii. We show here that the genus-specific PCR for the dnal gene of the mycobacteria and subsequent species-specific oligonucleotide probes are useful for differential diagnosis of tuberculosis and nontuberculous mycobacterial infections.
The mycobacteria examined in this study are listed in Table 1 . Strains were obtained from the National Institute of Health (Tokyo, Japan), the American Type Culture Collection (Rockville, Md.), and the National Collection of Type Cultures (London, United Kingdom). Mycobacteria from sputum samples were cultured by the sodium hydroxide digestion-decontamination method (18) . M. tuberculosis, M. avium, and M. intracellulare from the patients who possibly had tuberculosis were confirmed by the RNA-DNA hybridization method (Gen-Probe, Inc., San Diego, Calif.), whereas M. kansasii was identified by standard biochemical procedures (Kobayashi Pharmaceutical Co., Ltd., Osaka, Japan).
Genomic DNAs were isolated from cultured mycobacteria with sodium dodecyl sulfate (SDS) and phenol-chloroform. Briefly, one loop of the cultured mycobacteria was suspended in 500 ,ul of lx TE (10 mM Tris-HCl, 1 mM EDTA [pH 7.5]), the suspension was lysed with 0.5% SDS, and proteins were digested with 0.5 mg of proteinase K per ml for 15 min at 37°C. The DNAs were extracted by the addition of an equal volume of phenol-chloroform-isoamyl alcohol (25: 24:1). The aqueous phase was transferred to another tube, and DNAs were precipitated with sodium acetate (pH 5.5) and 2.5 volumes of ethanol for 30 min at -80°C. After centrifugation, the pellets were dissolved in 100 ,ul of 1 x TE, and 100 ng of the extracted DNA, of which the concentration was determined by the spectrophotometer (optical density at 260 nm, 50 ,ug/ml), was used for PCR.
DNA was amplified according to the procedures described below. PCR was performed in a volume of 50 ,ul containing 1 U of Taq polymerase (Perkin-Elmer Cetus, Norwalk, Conn.), 50 mM KCI, 10 mM Tris-HCl, 1.5 mM MgCl2, 0.01% gelatin, 50 pmol of each of the two primers, and 200 p,M of deoxynucleoside triphosphate mixtures (dATP, dCTP, dGTP, and dTTP). Fifty nanograms of DNA was added last in a volume of 2 pl. Amplification was repeated with 38 cycles of denaturation at 94°C for 30 s, primer annealing at 65°C for 1 min, and extension at 72°C for 2 min.
Primer development. PCR primers were based on the nucleotide sequences of the dnaJ gene of M. tuberculosis (7) . We first amplified the region between sequence positions 1377 and 1741 of M. tuberculosis with primer 1 (5'-AAGAG GAAGGAGAGAGGGG-3') and primer 2 (5'-GTCGTTGAG GTTGAACTC-3'). As shown in Fig. 1 , the initial PCR assay detected only predicted 365-bp DNA fragments of M. tuberculosis and M. avium but did not amplify any other species of mycobacteria. By sequencing the PCR products of M. tuberculosis and M. avium, we could identify a completely matching stretch of the nucleotide sequences between two species which allowed us to make primers 3 and 4 (primer 3, 5'-GGGTGACGCGGCATGGCCCA-3'; primer 4, 5'-CGGG TTTCGTCGTACTCCTT-3'). PCR with primers 3 and 4 successfully amplified the dnaJ genes of 18 mycobacterial species as a predicted 236-bp fragment, except in the case of M. chelonei (Fig. 2) . To amplify M. chelonei, we shifted the sequence of primer 3 by 5 bases upstream and the sequence of primer 4 by 6 bases upstream (primer 5, 5'-AGAGGGGG TGACGCGACATG-3'; primer 6, 5'-TCGTCGTACTCCT TGCGCTT-3'). All primers were synthesized on a 380A DNA Synthesizer (Applied Biosystems, Foster City, Calif.) with ,-cyanoethyl phosphoramidite chemistry.
Oligonucleotide probes. The amplified products were all subcloned into M13 vectors for single-stranded DNA sequencing by the dideoxy chain termination method (15) . To facilitate the subcloning of the amplified sequences, PCR products were reamplified for 20 cycles with primers 3 and 4 which include additional restriction sites for EcoRI and HindIII. Reamplified products were digested with EcoRI and HindIII and electrophoresed on agarose gel. After the DNA fragments were excised from the agarose gel, they were subcloned into M13mpl8 and M13mpl9. We determined the nucleotide sequences with at least four subclones to eliminate any incorrect sequences caused by misincorporation of nucleotides during PCR amplification.
We developed species-specific oligonucleotide probes for the PCR products from four mycobacterial species on the basis of the sequences of the individual dnaJ genes differing by more than two bases from each other (M. tuberculosis, 5'-ATCCGGACGCGAACCCGGGC-3'; M. avium, 5'-GGT CTCCGAGGCGCACAACG-3'; M. intracellulare, 5'-GGAC GCCAACCCGGACAATC-3'; M. kansasii, 5'-CTGAGGCC ACTGCTGAAGAA-3').
The oligonucleotides were labeled at the 5' end in 50 ,ul of Tris-HCl (pH 7.6)-10 mM MgCl2-5 mM dithiothreitol-0. ersham, Braunschweig, Germany), and 10 U of T4 polynucleotide kinase (Toyobo, Tokyo, Japan) by incubation for 30 min at 37°C. The enzyme was inactivated by incubation for 10 min at 95°C, and the labeled oligonucleotide was separated from residual [_y-32P]ATP with a spin column (Pharmacia-LKB, Uppsala, Sweden). The specific activities of the labeled oligonucleotides were 2 x 108 to 5 x 108 cpm/,Lg.
For the dot blot analysis, 2 ,ul of PCR products of the dnaJ gene was denatured by the addition of 100 ,ul of 0.1 N NaOH-10 mM Tris-HCl-1 mM EDTA, and the mixture was incubated for 5 min at room temperature. The samples were loaded into wells of a Bio-Dot apparatus (Bio-Rad Laboratories, Richmond, Calif.) fitted with a Hybond N nylon membrane (Amersham) prewetted in 2x SSC (2x SSC is 0.03 M sodium citrate, 0.3 M NaCl [pH 7.0]). After being blotted, the membrane was rinsed with 2x SSC and the DNA was immobilized on the membrane by UV irradiation. The membranes were prehybridized in a mixture containing 10 mM phosphate buffer, 100 ,ug of denatured salmon sperm DNA, 0.1% nonfat milk, and 0.1% SDS for 2 h at 62°C. Hybridization was performed with a mixture containing 3 M trimethylammonium chloride (8), 0.1% SDS, 100 p,g of denatured salmon sperm DNA, and 106 cpm of 5'-endlabeled oligonucleotide for 2 h at 62°C. The blots were washed four times for 5 min each at room temperature in 6x SSC. The blots were exposed to RX film (Fuji Film, Tokyo, Japan) with an amplifying screen for 1 h at -80°C.
Among the species of the M. tuberculosis complex, such as M. tuberculosis, M. bovis, M. bovis BCG, M. africanum, and M. microti, the nucleotide sequences of the amplified dnaJ genes were completely identical. We further found that there were many substitutions in the nucleotide sequences of the amplified dnaJ genes among species of the nontuberculous mycobacterial group (data not shown). As shown in Fig.  3 , the oligonucleotide probes complementary to the dnaJ genes of M. tuberculosis, M. bovis, M. avium, M. intracellulare, and M. kansasii hybridized strongly to the amplified PCR products of the corresponding species but did not hybridize at all to those of other mycobacterial species. Furthermore, the oligonucleotide probes hybridized specifically to the PCR products from five clinical isolates for each species. The sensitivities of the dot blot analyses among the four species-specific oligonucleotide probes developed in this study were compared. The extracted DNAs from cul- tured mycobacterial species such as M. tuberculosis, M. avium, M. intracellulare, and M. kansasii were serially diluted and subjected to PCR with primers 3 and 4. Amplified products were analyzed by the dot blot hybridization method described above. Figure 4 shows that three oligonucleotide probes, such as those for M. tuberculosis, M. avium, and M. intracellulare, have similar sensitivities in detecting mycobacteria for each species, which could be detected by as little as 50 fg of the mycobacterial DNAs (equivalent to approximately 10 mycobacterial genomes). The oligonucleotide probe for M. kansasii, which could detect 5 pg of the mycobacterial DNA, was 100 times less sensitive than the other three probes.
Our aim was to develop a rapid and specific laboratory test for detecting and identifying mycobacteria within clinical samples. For this purpose, we developed a dot blot hybridization assay with oligonucleotide probes that could sensitively and specifically identify clinically important mycobacterial species such as those of the M. tuberculosis complex, M. avium, M. intracellulare, and M. kansasii. Boddinghaus et al. also reported that rRNA can be a general target for developing species-specific oligonucleotide probes (1) and demonstrated the specificities of the species-specific probes for M. tuberculosis, M. avium, and M. intracellulare. Our results were comparable to theirs in that M. tuberculosis, M. avium, and M. intracellulare can be specifically identified with oligonucleotide probes. Our system, however, is unique because reverse transcription is not necessary to detect the dnaJ genes and because M. kansasii can also be recognized with one of our probes. At the same time, the dnaJ gene sequences are more useful than rRNA as a target for developing species-specific oligonucleotide probes because the nucleotide sequences of the dnaJ genes are highly variable among nontuberculous mycobacteria.
In summary, we have demonstrated that PCR for the dnaJ
